Interleukin-24 therapy- a potential new strategy against liver fibrosis

Affiliations

• ¹ Central Texas Veterans Health Care System, Temple, Texas; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas.
• ² Central Texas Veterans Health Care System, Temple, Texas; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas; Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, Texas. Electronic address: sharon.demorrow@austin.utexas.edu.